logo
Select company
Select metric
-377.89%EBIT Margin
VS
Market
8
Sector
27
Industry
48
History
50
$ 2.01Close
$ 0.71 - $ 2.05 52-Week Range
Ticker Information

Ticker

IRD

Company Name

OPUS GENETICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

OPUS GENETICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IRD - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -58.27M-377.89%$ 15.42M
3/31/2025$ -58.62M-429.42%$ 13.65M
12/31/2024$ -57.53M-523.4%$ 10.99M
9/30/2024$ -27.19M-324.47%$ 8.38M
6/30/2024$ -14.09M-85.68%$ 16.45M
3/31/2024$ -11.29M-59.38%$ 19.01M
12/31/2023$ -9.97M-52.36%$ 19.05M
9/30/2023$ 29.08M50.83%$ 57.21M
6/30/2023$ 18.97M41.91%$ 45.27M
3/31/2023$ 19.01M45.7%$ 41.6M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • OPUS GENETICS INC's latest trailing twelve months (TTM) EBIT % stands at -553.94%.
  • Over the past 5 years, OPUS GENETICS INC's average EBIT % has been -1365.16%.
  • The median EBIT % for OPUS GENETICS INC during this period was -324.47%
  • OPUS GENETICS INC reached its highest EBIT % over the past 5 years at 50.83%.
  • The lowest EBIT % recorded by OPUS GENETICS INC in the same timeframe -9624.96%

OPUS GENETICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
VRCA : VERRICA PHARMACEUTICALS INC -268.91%BRNS : BARINTHUS BIOTHERAPEUTICS PLC -463.75%EQ : EQUILLIUM INC -119.82%HYFT : MINDWALK HOLDINGS CORP -143.91%XLO : XILIO THERAPEUTICS INC -374.79%CUE : CUE BIOPHARMA INC -463.15%SRZN : SURROZEN INC -325.06%WHWK : WHITEHAWK THERAPEUTICS INC -48.06%OVID : OVID THERAPEUTICS INC -574.02%SEER : SEER INC -504.64%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for OPUS GENETICS INC is calculated as follows: EBIT [ $ -6.37M ] / Revenues [ $ 1.15M ]
(=) EBIT % [ -553.94% ]

IRD - EBIT Margin, Last 5 years

-9624.96%

Minimum

Dec 31, 2021

50.83%

Maximum

Sep 30, 2023

-1365.16%

Average

-324.47%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%